Influence
August 24, 2021

Regenstrief research scientist contributes to new national stroke treatment guideline

A Regenstrief Institute research scientist has helped author new national guidelines to reduce the risk of a second stroke.

Neurologist Linda Williams, M.D., is a member of the American Heart Association writing group for the updated guideline titled “2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack.”  In addition to her role at Regenstrief, Dr. Williams is affiliated with the U.S. Department of Veterans Affairs and Indiana University School of Medicine.

The new guideline encourages providers to tailor stroke prevention strategies based on the cause of the stroke.

Dr. Williams is an experienced neurologist who has conducted extensive research on stroke and TIA care. In this report, she authored the sections on homocysteine, embolic stroke of undetermined source and the use of antithrombotic medications.

As a writing group member, Dr. Williams reviewed all sections of the guidelines. This update is the first since 2014.

About Linda Williams, M.D.

In addition to her role as a research scientist at Regenstrief, Linda S. Williams, M.D., is a core investigator for the U.S. Department of Veterans Affairs Health Services Research and Development Center for Health Information and Communication, Richard L. Roudebush VA Medical Center. She also is a professor of neurology at Indiana University School of Medicine.

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher